NOV 20, 2018 3:43 PM PST

Survival of the SCID Patient

WRITTEN BY: Nicholas Breehl

A recent study highlights the effectiveness of treatments provided to patients of severe combined immunodeficiency (SCID). The study reveals a relationship between the genotype of the patients SCID and the efficacy of a stem cell transplant in regards to immune system reconstitution and survival rates. The study’s lead researcher is a pediatric immunologist at CHU Sainte-Justine and professor at Université de Montréal, Dr. Elie Haddad.

Severe combined immunodeficiency or SCID is an inherited immune system disorder characterized by abnormalities with responses of both T cells and B cells – the white blood cells needed for immune system function). Common signs and symptoms include increased susceptibility to infections including ear infections; pneumonia or bronchitis; oral thrush; and diarrhea.

SCID may be caused by mutations in any of several genes and can be inherited in an X-linked recessive (most commonly) or autosomal recessive manner. The most common type of SCID is the X-linked severe combined immunodeficiency (XSCID).

The study was international and included the medical history of more than 600 patients ranging from 1982-2012 in over 30 different centers. The study published in Blood incorporated those SCID individuals that received a hematopoietic stem cell transplant as their therapy.

"Immune diseases are among the top priorities at CHU Sainte-Justine in terms of care, teaching, and research," Haddad said. "There are only one or two cases of SCID per year in Quebec. Having access to such a cohort of patients with this rare disease and over such a long period has provided us with significant and unique data to advance our knowledge in this area."

After reviewing the data, the results describe survival rates of patients who receive stem cell transplants from related donors are most successful. While around 86 percent of patients who undergo stem cell transplants are from non-related donors and the success of their therapy is strongly impacted by the genotype of the patient.

Interestingly, the data show the lower the age of the patient and the absence of infection during therapy increased the success of the transplant and the longevity of the patient thereafter.

"We need to develop patient-specific treatment strategies," Haddad said. "There is a critical need for neonatal screening to establish appropriate isolation, implement infection-prevention measures, particularly before transplantation, and ensure rapid referral for bone-marrow transplant or gene therapy after diagnosis."

"In our future research, our objective will be to analyze the late effects of conditioning and the quality of long-term immune-system reconstitution after hematopoietic cell transplant for this deficiency," said Haddad. Finally, the scientists remark, “Our data emphasize the need for patient-tailored treatment strategies depending upon the underlying SCID genotype.”

Sources: Blood, Science Daily, NIH, YouTube

About the Author
You May Also Like
MAR 11, 2021
Immunology
Bye-Bye Burning: A New UTI Vaccine
MAR 11, 2021
Bye-Bye Burning: A New UTI Vaccine
Researchers have developed a vaccine that “trains” the bladder to fight back against the bacteria that cause ...
MAR 23, 2021
Immunology
Assay Detects Antibodies in Asymptomatic COVID Carriers
MAR 23, 2021
Assay Detects Antibodies in Asymptomatic COVID Carriers
It is estimated that around one in five people infected with SARS-CoV-2 will not show any infection symptoms. Some of th ...
APR 06, 2021
Immunology
Lymphoma Patient Cured by "Reeducating" their Immune System
APR 06, 2021
Lymphoma Patient Cured by "Reeducating" their Immune System
Australian researchers have used a breakthrough therapy to cure a patient diagnosed with a rare brain lymphoma, a form o ...
APR 06, 2021
Cell & Molecular Biology
New Insight Into a Crucial Immune Cell
APR 06, 2021
New Insight Into a Crucial Immune Cell
Dendritic cells are a crucial part of the immune response; they look out for the presence of pathogenic invaders like vi ...
APR 05, 2021
Cannabis Sciences
Does Cannabis Damage the Immune System?
APR 05, 2021
Does Cannabis Damage the Immune System?
Increasingly, cannabis is being hailed as a wonderdrug- treating ailments from pain to inflammation and even COVID- ...
APR 03, 2021
Cancer
New factor plays a key role in immune response
APR 03, 2021
New factor plays a key role in immune response
In a study published recently in Science Immunology, WEHI’s Professor Stephen Nutt, Dr. Michael Chopin, and Mr. Sh ...
Loading Comments...